Cabaletta Stock Analysis

CABA Stock  USD 11.86  0.74  6.65%   
The current price rise of Cabaletta Bio could raise concerns from investors as the firm is trading at a share price of 11.86 on 1,165,922 in volume. The company executives may have good odds in positioning the firm resources to exploit market volatility in February. The stock standard deviation of daily returns for 90 days investing horizon is currently 9.53. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Cabaletta Bio partners.
Continue to Trending Equities.
The Cabaletta Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Cabaletta Bio is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, Christmas Day ( substitute day ), New Year 's Monday, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Cabaletta Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Cabaletta Bio's ongoing operational relationships across important fundamental and technical indicators.

Cabaletta Stock Analysis Notes

About 58.0% of the company shares are held by institutions such as insurance companies. The book value of Cabaletta Bio was currently reported as 2.96. The company recorded a loss per share of 1.84. Cabaletta Bio had not issued any dividends in recent years. Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania. Cabaletta Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 57 people. For more info on Cabaletta Bio please contact the company at 267 759 3100 or go to

Cabaletta Bio Upcoming and Recent Events

Earnings reports are used by Cabaletta Bio to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cabaletta Bio previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report15th of March 2022
Next Financial Report2nd of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End15th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Cabaletta Bio SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Cabaletta Bio prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Cabaletta Bio investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Cabaletta Bio specific information freely available to individual and institutional investors to make a timely investment decision.
12th of September 2022
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure
29th of August 2022
Financial Statements and Exhibits. Other Events
22nd of August 2022
Unclassified Corporate Event
11th of August 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
3rd of August 2022
Unclassified Corporate Event
2nd of June 2022
Submission of Matters to a Vote of Security Holders
18th of May 2022
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure
12th of May 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition

Cabaletta Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 324.05 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cabaletta Bio's market, we take the total number of its shares issued and multiply it by Cabaletta Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Cabaletta Profitablity

Cabaletta Bio's profitability indicators refer to fundamental financial ratios that showcase Cabaletta Bio's ability to generate income relative to its revenue or operating costs. If, let's say, Cabaletta Bio is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Cabaletta Bio's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Cabaletta Bio's profitability requires more research than a typical breakdown of Cabaletta Bio's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2023
Return on Average Assets(34.56) (37.29) 
Return on Average Equity(36.62) (39.52) 
Return on Invested Capital(85.02) (87.26) 

Management Efficiency

The entity has return on total asset (ROA) of (0.3017) % which means that it has lost $0.3017 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (0.5054) %, meaning that it created substantial loss on money invested by shareholders. Cabaletta Bio management efficiency ratios could be used to measure how well cabaletta bio manages its routine affairs as well as how well it operates its assets and liabilities. As of January 27, 2023, Return on Average Assets is expected to decline to -37.29. In addition to that, Return on Average Equity is expected to decline to -39.52. Cabaletta Bio Total Assets Per Share are projected to slightly grow based on the last few years of reporting. The past year's Total Assets Per Share were at 3.93. The current year Net Current Assets as percentage of Total Assets is expected to grow to 89.28, whereas Total Assets are forecasted to decline to about 94.9 M.
Last ReportedProjected for 2023
Book Value per Share 4.79  5.17 
Enterprise Value over EBIT(6.90) (7.44) 
Enterprise Value over EBITDA 0.27  0.29 
Price to Book Value 0.82  1.28 
Tangible Assets Book Value per Share 4.01  5.73 
Enterprise Value-9.8 M-10.1 M
Tangible Asset Value145.3 M136.8 M
Non Current Liabilities Total
Interest Expense
Total Operating Expenses
46.3 M
Non Current Assets Total
1.8 M

Technical Drivers

As of the 27th of January, Cabaletta Bio shows the mean deviation of 7.28, and Risk Adjusted Performance of 0.3807. Cabaletta Bio technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed nineteen technical drivers for Cabaletta Bio, which can be compared to its rivals. Please confirm Cabaletta Bio mean deviation, standard deviation, treynor ratio, as well as the relationship between the downside deviation and information ratio to decide if Cabaletta Bio is priced correctly, providing market reflects its regular price of 11.86 per share. Given that Cabaletta Bio has jensen alpha of 2.99, we suggest you to validate Cabaletta Bio's prevailing market performance to make sure the company can sustain itself at a future point.

Cabaletta Bio Price Movement Analysis

Execute Study
The output start index for this execution was fourty-eight with a total number of output elements of thirteen. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Cabaletta Bio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Cabaletta Bio. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Cabaletta Bio Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cabaletta Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cabaletta Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cabaletta Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Cabaletta Bio Predictive Daily Indicators

Cabaletta Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cabaletta Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Cabaletta Bio Forecast Models

Cabaletta Bio time-series forecasting models is one of many Cabaletta Bio's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cabaletta Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Cabaletta Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cabaletta Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cabaletta shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Cabaletta Bio. By using and applying Cabaletta Stock analysis, traders can create a robust methodology for identifying Cabaletta entry and exit points for their positions.
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania. Cabaletta Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 57 people.

Current Cabaletta Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cabaletta analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cabaletta analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Cabaletta Bio current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Cabaletta analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cabaletta stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cabaletta Bio, talking to its executives and customers, or listening to Cabaletta conference calls.
Cabaletta Analyst Advice Details

Cabaletta Stock Analysis Indicators

Cabaletta Bio stock analysis indicators help investors evaluate how Cabaletta Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Cabaletta Bio shares will generate the highest return on investment. By understating and applying Cabaletta Bio stock analysis, traders can identify Cabaletta Bio position entry and exit signals to maximize returns.
Begin Period Cash Flow101.4 M
Common Stock Shares Outstanding21.5 M
Total Stockholder Equity118 M
Total Cashflows From Investing ActivitiesM
Property Plant And Equipment Net1.4 M
Retained Earnings-112.6 M
Cash And Short Term Investments122.2 M
Cash122.2 M
Accounts Payable2.3 M
Net Debt-122.2 M
50 Day M A7.0188
Total Current Liabilities8.4 M
Non Current Assets Total1.8 M
Non Currrent Assets Other357 K
Continue to Trending Equities. Note that the Cabaletta Bio information on this page should be used as a complementary analysis to other Cabaletta Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Cabaletta Stock analysis

When running Cabaletta Bio price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Is Cabaletta Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
324 M
Return On Assets
Return On Equity
The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Cabaletta Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.